|
HY-10330-5mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330-50mg
|
MedChemexpress LLC
|
Toceranib [CAS 356068-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-10mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-100mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-25mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-5mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10330A-50mg
|
MedChemexpress LLC
|
Toceranib (phosphate) [CAS 874819-74-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10408-10mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10408-2mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10408-5mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10408-50mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-112616-10mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-100mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-25mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-5mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112616-50mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
|
HY-123450-10mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-100mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-25mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-5mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-123450-50mg
|
MedChemexpress LLC
|
S116836 [CAS 1257628-57-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-10mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-100mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-200mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-5mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
